BPC-157 is not on the FDA's approved drug list, but the bulk active ingredient is permitted for compounding by a 503A pharmacy under Section 503A of the Federal Food, Drug, and Cosmetic Act
Mechanisms of action Preclinical studies document: Anxiolytic effect without sedation in classical tests (elevated plus maze, open field, light-dark box) GABAergic system modulation : allosteric potentiation of GABA-A observed ex vivo Enkephalin increase (endogenous opioid peptide) and serotonergic modulation Immunomodulatory effects inherited from tuftsin: macrophage activation, T-helper modulation Behavioural models Anxiolysis is measured via time spent in open arms of the elevated plus maze (EPM), visit ratio of central zones of open field , and exit latency in light-dark box
Strength: 1,000mcg/mL (10,000mcg/10mL) Bacteriostatic water and mixing syringe will be provided for reconstitution
Make sure to use the proper technique to ensure that Petide is evenly dissolved
References Kapoor R, Shome D, Vadera S, Kumar V, Ram MS
In addition, other tissue metabolism also obstacles, such as nervous system damage